Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Lakehouse Small Companies Fund 2024 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Lakehouse Small Companies Fund)

Primary Source Intelligence • Q2 2024 Letter Analysis

Lakehouse Small Companies Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Lakehouse Small Companies Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+9%

Digest Analysis

Quick Take

"The concentrated 22-stock portfolio emphasizes long-term growth over short-term noise, with heavy technology and healthcare weightings."

Executive Summary

Lakehouse Small Companies Fund delivered strong performance in FY2024, returning 26.8% net versus 9.3% for its benchmark, driven by a concentrated portfolio of 22 quality companies. The fund's investment philosophy centers on extreme customer loyalty as demonstrated by Xero's 90% retention rate versus competitors at 80%, creating exponential differences in customer lifetime value. Top contributors included Pro Medicus with record contract wins and cloud adoption, Altium which was acquired by Renesas, and Audinate continuing its digital audio network expansion. Healthcare positions faced headwinds with Nanosonics declining on hospital budget constraints and Impedimed experiencing board upheaval. The fund maintains sector allocations heavily weighted toward information technology (40.1%), financials (18.8%), and healthcare (17.5%), contrasting sharply with the materials-heavy benchmark. With cash at 5.7% and an average holding period exceeding five years, the manager emphasizes patience and long-term value creation while actively managing position sizes based on valuations and business fundamentals.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

78%

CautiousHigh

High Conviction (78%)

High conviction evidenced by concentrated 22-stock portfolio with top 5 holdings at 38.8%, average holding period exceeding 5 years, and specific position sizing discussions. Manager names individual holdings, discusses thesis details, and demonstrates willingness to hold through volatility as shown with Altium's 44% drawdown.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager acknowledges market volatility and gyrations but frames them as normal wealth compounding patterns. While noting challenges in healthcare budgets and some sector headwinds, the overall tone suggests markets provide long-term opportunities for patient investors.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

Cash decreased from 8.7% to 5.7% during the year, indicating moderate deployment. The fund maintains a concentrated 22-stock portfolio with high conviction positions, suggesting a risk-on tilt while maintaining some defensive cash allocation.

Capital Deployment

25%

De-riskingDeploying

De-risking (25%)

Cash decreased from 8.7% to 5.7% representing moderate deployment of approximately 3 percentage points. The fund also exited 2 positions and opened 4 new ones, indicating selective capital rotation and modest net deployment activity.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The manager expresses excitement about watching investment cases unfold in coming years and maintains conviction in long-term thesis, but acknowledges near-term challenges in healthcare and emphasizes patience rather than aggressive deployment.

Language Signal

20%

BearishBullish

Bearish (20%)

Language is balanced with positive terms like 'excited', 'pleasing', and 'strong' offset by risk discussions around volatility, budget constraints, and market challenges. The tone is constructive but measured rather than overwhelmingly bullish.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Manager acknowledges standard market risks including volatility, hospital budget constraints, and sector-specific challenges. Risk discussion is present but not central to the letter, with emphasis on managing through cycles rather than avoiding risk entirely.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Manager demonstrates selective opportunity identification by opening 4 new positions while maintaining concentrated approach. Discussion of specific growth runways and market penetration opportunities suggests moderate opportunity set requiring selectivity rather than abundance.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Explicitly emphasizes investment horizon much longer than 12 months, with average holding period exceeding 5 years and discussion of multi-year thesis development. Manager focuses on long-term value creation and demonstrates patience through market cycles, though not permanent capital structure.